Research graph
References from Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Cancer statistics, 2016
10.3322/caac.21332 · 2016 · External reference
Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
10.1093/annonc/mdq191 · 2010 · External reference
Cigarette smoking and lung cancer-relative risk estimates for the major histological types from a pooled analysis of case–control studies
10.1002/ijc.27339 · 2012 · External reference
Small-cell lung cancer
10.1016/s0140-6736(11)60165-7 · 2011 · External reference
Temporal trends in small cell lung cancer: analysis of the national Surveillance, Epidemiology, and End-Results (SEER) database
10.1200/jco.2006.24.18_suppl.7082 · 2006 · External reference
Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers
10.1097/jto.0b013e31820c2f2e · 2011 · External reference
Treatment of small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines
10.1378/chest.12-2363 · 2013 · External reference
Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
10.1093/annonc/mdt178 · 2013 · External reference
A meta-analysis of thoracic radiotherapy for small-cell lung cancer
10.1056/nejm199212033272302 · 1992 · External reference
Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America
10.1002/cncr.10841 · 2002 · External reference
Small-cell lung cancer
10.1016/s0140-6736(05)67569-1 · 2005 · External reference
Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study
10.1016/j.ijrobp.2004.12.019 · 2005 · External reference
Involved-field radiation therapy for inoperable non small-cell lung cancer
10.1200/jco.2007.13.2191 · 2007 · External reference
Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer
10.1186/1748-717x-4-5 · 2009 · External reference
Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial
10.1016/j.radonc.2006.07.029 · 2006 · External reference
Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study
10.1016/j.ijrobp.2009.04.075 · 2010 · External reference
Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: report of Radiation Therapy Oncology Group (RTOG) protocol 97–12
10.1016/j.ijrobp.2004.11.030 · 2005 · External reference
Unresolved reference
External reference
Staging nodal disease in non-small cell lung cancer: implications for radiation therapy
10.1097/jto.0b013e31807a2fbe · 2007 · External reference
International Association for the Study of Lung Cancer (IASLC) lymph node map: radiologic review with CT illustration
10.1148/rg.346130097 · 2014 · External reference
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide
10.1056/nejm199901283400403 · 1999 · External reference
Time in radiation oncology – keep it short!
10.1016/j.radonc.2013.03.007 · 2013 · External reference
Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years’ follow-up
10.1200/jco.2002.12.111 · 2002 · External reference
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104
10.1200/jco.2002.12.071 · 2002 · External reference
Prophylactic cranial irradiation for patients with lung cancer
10.1016/s1470-2045(16)30065-1 · 2016 · External reference
Locoregional failures following thoracic irradiation in patients with limited-stage small cell lung carcinoma
10.1016/j.radonc.2011.12.009 · 2012 · External reference
Is involved-field radiotherapy based on CT safe for patients with limited-stage small-cell lung cancer?
10.1016/j.radonc.2011.10.003 · 2012 · External reference
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
10.1016/s1470-2045(17)30318-2 · 2017 · External reference
Feasibility and efficacy of simultaneous integrated boost intensity-modulated radiation therapy in patients with limited-disease small cell lung cancer
10.1186/s13014-014-0280-9 · 2014 · External reference
Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer-evidence from a phase II trial
10.1016/j.lungcan.2011.09.015 · 2012 · External reference
Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival
10.1111/j.1754-9485.2010.02201.x · 2010 · External reference
Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer
10.1016/j.ijrobp.2010.12.072 · 2012 · External reference
Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancer
10.1016/j.athoracsur.2014.05.078 · 2014 · External reference
Current clinical trials testing the combination of immunotherapy with radiotherapy
10.1186/s40425-016-0156-7 · 2016 · External reference
Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging
10.1016/j.radonc.2017.08.010 · 2017 · External reference
Phase III randomized trial of ipilimumab plus etoposide and platinum versus placebo plus etoposide and platinum in extensive-stage small-cell lung cancer
10.1200/jco.2016.67.6601 · 2016 · External reference
Outcome and biomarker analysis from a multicenter phase 2 study of ipilimumab in combination with carboplatin and etoposide as first-line therapy for extensive-stage SCLC
10.1016/j.jtho.2016.05.028 · 2016 · External reference
Recent advances and future strategies for immune-checkpoint inhibition in small-cell lung cancer
10.1016/j.cllc.2016.07.004 · 2017 · External reference
Radiation oncology in the era of precision medicine
10.1038/nrc.2016.18 · 2016 · External reference
Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer
10.1016/j.ijrobp.2012.10.003 · 2013 · External reference
Clinical perspectives of cancer stem cell research in radiation oncology
10.1016/j.radonc.2013.06.002 · 2013 · External reference
Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients
10.1016/j.lungcan.2009.04.006 · 2010 · External reference
Prognostic factors including the expression of thyroid transcription factor 1 (TTF1) in patients irradiated for limited-disease small cell lung cancer
2016 · External reference
